CDC Epidemiologist to Host Congenital CMV Webinar

Dr. Michael Cannon, a research epidemiologist at the National Center on Birth Defects and Developmental Disabilities at the CDC, will be hosting a webcast discussing congenital cytomegalovirus (cCMV) this Thursday, August 21st at 1:30PM EST. Learn more about the Webcast and Register >>

Dr. Cannon conducts research on the prevention of birth defects, with a particular focus on congenital cytomegalovirus, the most common congenital infection in babies in developed countries. Dr. Cannon will be providing an overview of cCMV prevention, diagnosis, and treatment.

Pregnant women who contract cCMV can pass the virus onto their unborn baby, which can result in multiple developmental disabilities, including hearing and vision loss, small head size, and a lack of coordination. Ross and Fowler (2008) estimate that cCMV is responsible for 15%-21% of hearing loss in children. While the effects of cCMV have been known for more than twenty years, many people are still unaware of the virus and its negative effect on unborn babies.

About VBI Vaccines

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. Learn More >>